RB1 and neoplasm: As indirect evidence, CDK4/6 inhibitors can suppress RB1 expression [34, 35], and antagonize the anti‐tumor effects of thiopurine (i.e., 6MP, azathioprine, and thioguanosine), which may be induced by coactivated NUDT15 expression [49].